Rheumer Has It: Busting Medication Myths with Dr. Hazelwood
In this episode of Rheumer Has It, hosts Eileen and Cheryl sit down with rheumatologist Dr. Glenn Hazelwood to debunk common myths and misunderstandings about medications for treating rheumatic diseases like rheumatoid arthritis.
Audio is streamed directly from the publisher (afp-935238-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The discussion addresses concerns about medication side effects, the importance of treating rheumatic diseases early, and the false stigma that using advanced treatments indicates more severe disease or personal failure.
Dr. Hazelwood emphasizes the importance of balancing risks and benefits and provides insights into how modern treatments can significantly improve quality of life. The episode emphasizes the safety and necessity of these medications and highlights the benefits of starting treatment early to prevent long-term complications.
This episode is particularly valuable for anyone newly diagnosed with rheumatoid arthritis who is navigating the complexities and concerns surrounding medication.
Episode at a glance:
- Meet Rheumatologist & Researcher Dr. Glenn Hazelwood:
- Busting Myths About Medications
- Challenging Stigmas Around Advanced Treatments
- Addressing Misconceptions About Medication Use
Medical disclaimer:
All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Episode Sponsors
Rheum to THRIVE, an online course and support program Cheryl Crow, OT created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.